ATARA BIOTHERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $13.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-16
- ATARA BIOTHERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $13.40M, a 87.43% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $106.60M, a 103.05% increase from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $52.50M, a 13.15% increase from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $46.40M, a 47.69% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 4 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2025-12-31 | $13.40M 10-K · filed 2026-03-16 | |
| 2024-12-31 | $106.60M 10-K · filed 2026-03-16 | |
| 2023-12-31 | $52.50M 10-K · filed 2024-03-28 | |
| 2022-12-31 | $46.40M 10-K · filed 2023-02-08 | |
| 2021-12-31 | $88.70M 10-K · filed 2022-02-28 | |
| 2020-12-31 | $82.10M 10-K · filed 2021-03-01 | |
| 2019-12-31 | $78.10M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $79.90M 10-K · filed 2020-02-27 | |
| 2017-12-31 | -$8.60M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $18.90M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $23.30M 10-K · filed 2017-03-09 | |
| 2014-12-31 | $9.20M 10-K · filed 2017-03-09 | |
| 2013-12-31 | $2.90M 10-K · filed 2016-03-04 | |
| 2012-12-31 | $1.60M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |